Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
289
1.630
Why?
Carcinoma, Squamous Cell
15
2010
331
1.540
Why?
DNA Methylation
13
2009
573
1.060
Why?
DNA Glycosylases
5
2011
19
0.980
Why?
Promoter Regions, Genetic
11
2009
465
0.980
Why?
Gene Silencing
7
2009
122
0.970
Why?
Mitochondria
3
2011
420
0.480
Why?
DNA Repair
5
2008
194
0.470
Why?
Polymerase Chain Reaction
11
2009
458
0.450
Why?
Adaptor Proteins, Signal Transducing
5
2009
202
0.450
Why?
Kidney Neoplasms
2
2008
181
0.440
Why?
DNA, Neoplasm
10
2008
146
0.430
Why?
Nuclear Proteins
5
2009
247
0.430
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
177
0.420
Why?
Neoplasm Proteins
4
2005
328
0.390
Why?
Laryngeal Neoplasms
3
2007
43
0.360
Why?
Vascular Endothelial Growth Factor A
2
2009
186
0.350
Why?
CpG Islands
3
2008
111
0.340
Why?
Lung Neoplasms
2
2007
643
0.320
Why?
Microsatellite Instability
1
2009
21
0.310
Why?
Fatty Liver
1
2011
141
0.310
Why?
Immunohistochemistry
7
2012
977
0.310
Why?
Mitochondrial Proteins
2
2007
91
0.300
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
24
0.290
Why?
Port-Wine Stain
1
2008
14
0.290
Why?
Oxygen
1
2011
332
0.290
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
9
0.280
Why?
Lymph Nodes
2
2007
253
0.270
Why?
Genes, p16
3
2005
9
0.270
Why?
DNA, Mitochondrial
4
2011
112
0.270
Why?
N-Glycosyl Hydrolases
1
2007
6
0.270
Why?
Skin
3
2010
416
0.270
Why?
Carcinoma, Renal Cell
1
2008
112
0.260
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
15
0.260
Why?
Adenoma
1
2008
114
0.260
Why?
Mitochondria, Liver
1
2007
69
0.260
Why?
Aged
15
2011
10242
0.260
Why?
Cisplatin
3
2007
282
0.250
Why?
Proteoglycans
2
2003
86
0.240
Why?
Fibroma
1
2006
40
0.240
Why?
Liver
1
2011
1150
0.230
Why?
Aged, 80 and over
8
2009
3449
0.230
Why?
Membrane Glycoproteins
2
2003
239
0.230
Why?
Survival Analysis
5
2009
656
0.220
Why?
Middle Aged
16
2011
13133
0.220
Why?
Carcinoma, Hepatocellular
1
2007
208
0.220
Why?
Humans
36
2013
52441
0.220
Why?
DNA Repair Enzymes
1
2004
42
0.210
Why?
Prognosis
7
2007
2100
0.210
Why?
Ataxia Telangiectasia
1
2004
6
0.210
Why?
Salivary Ducts
1
2003
3
0.210
Why?
Salivary Gland Neoplasms
1
2003
7
0.210
Why?
Adenocarcinoma, Clear Cell
1
2003
34
0.210
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
67
0.200
Why?
Liver Neoplasms
1
2007
341
0.200
Why?
Obesity
1
2011
1176
0.190
Why?
Adult
14
2011
14205
0.190
Why?
Nitric Oxide Synthase Type III
2
2013
83
0.180
Why?
Female
22
2012
28277
0.180
Why?
Male
21
2012
26874
0.180
Why?
Epigenesis, Genetic
1
2004
396
0.170
Why?
Transcription Factors
1
2003
570
0.160
Why?
Antineoplastic Agents
2
2010
1216
0.160
Why?
Skin Transplantation
2
2010
43
0.150
Why?
Skin Neoplasms
4
2008
496
0.150
Why?
Carrier Proteins
4
2005
312
0.150
Why?
Tumor Suppressor Proteins
2
2011
127
0.140
Why?
Loss of Heterozygosity
2
2008
78
0.140
Why?
DNA Damage
2
2011
298
0.130
Why?
Survival Rate
3
2009
944
0.130
Why?
Neoplasm Invasiveness
4
2007
278
0.120
Why?
Graft Survival
3
2011
157
0.110
Why?
Ki-67 Antigen
2
2011
57
0.110
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
580
0.110
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
34
0.110
Why?
Cadherins
2
2005
61
0.110
Why?
Immunoenzyme Techniques
4
2013
134
0.110
Why?
Prostatic Neoplasms
2
2008
398
0.110
Why?
Algorithms
2
2008
673
0.110
Why?
Thyroid Neoplasms
2
2007
111
0.110
Why?
Keratosis
2
2003
14
0.100
Why?
Base Sequence
2
2004
632
0.090
Why?
Receptors, Cell Surface
1
2013
111
0.090
Why?
Carcinoma in Situ
2
2003
72
0.090
Why?
Lymphangioma, Cystic
1
2011
9
0.090
Why?
Laryngectomy
3
2007
27
0.090
Why?
Leukoplakia, Oral
1
2011
6
0.090
Why?
Aminolevulinic Acid
1
2011
9
0.090
Why?
Arteriovenous Malformations
1
2013
74
0.090
Why?
Endothelium, Lymphatic
1
2011
8
0.090
Why?
Antigens, CD
1
2013
213
0.090
Why?
Lasers, Dye
1
2011
10
0.090
Why?
Cell Line, Tumor
4
2010
1429
0.090
Why?
Photosensitizing Agents
1
2011
20
0.090
Why?
Wound Healing
2
2010
223
0.090
Why?
Lymphatic Abnormalities
1
2011
20
0.090
Why?
Propranolol
1
2012
76
0.090
Why?
Microtubule-Associated Proteins
1
2011
61
0.090
Why?
Photochemotherapy
1
2011
32
0.090
Why?
Biopsy
3
2011
594
0.090
Why?
Homeodomain Proteins
1
2011
80
0.090
Why?
Laser Therapy
1
2011
74
0.090
Why?
Taxoids
1
2010
38
0.090
Why?
Drug Resistance, Multiple
1
2010
25
0.080
Why?
Hemangioma
1
2012
86
0.080
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
60
0.080
Why?
Follow-Up Studies
4
2011
2294
0.080
Why?
Gene Deletion
1
2011
279
0.080
Why?
Neoplasm Staging
3
2007
768
0.080
Why?
Gene Expression Regulation, Neoplastic
4
2010
853
0.080
Why?
Mice, Transgenic
1
2011
566
0.080
Why?
Disease Models, Animal
2
2011
1483
0.080
Why?
Animals
8
2011
13485
0.070
Why?
Paraffin Embedding
1
2008
52
0.070
Why?
Sulfites
1
2008
2
0.070
Why?
Mice
4
2011
5899
0.070
Why?
Microsatellite Repeats
1
2008
42
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1020
0.070
Why?
Blood Glucose
1
2011
483
0.070
Why?
Neoplasm Seeding
1
2008
4
0.070
Why?
Drug Resistance, Neoplasm
1
2010
336
0.070
Why?
Chordoma
1
2008
9
0.070
Why?
Skull Base Neoplasms
1
2008
20
0.070
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.070
Why?
Laryngeal Nerves
1
2007
15
0.070
Why?
Apoptosis Regulatory Proteins
2
2005
84
0.070
Why?
Receptors, Thyrotropin
1
2007
6
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
62
0.070
Why?
Methylation
2
2007
124
0.070
Why?
Symporters
1
2007
18
0.070
Why?
Cell Proliferation
1
2011
1013
0.070
Why?
Image Enhancement
1
2007
47
0.070
Why?
Pattern Recognition, Automated
1
2007
39
0.070
Why?
Precancerous Conditions
1
2008
87
0.070
Why?
Prostate
1
2008
116
0.070
Why?
Risk Factors
3
2008
3971
0.070
Why?
Carcinoma, Papillary
1
2007
49
0.070
Why?
Transgenes
1
2007
55
0.070
Why?
Neoplasm Recurrence, Local
2
2008
639
0.070
Why?
Image Interpretation, Computer-Assisted
1
2007
96
0.060
Why?
Child, Preschool
3
2012
4046
0.060
Why?
Cell Nucleus
1
2007
189
0.060
Why?
Child
5
2012
7194
0.060
Why?
MicroRNAs
1
2010
392
0.060
Why?
Syndecans
2
2003
37
0.060
Why?
Protein Transport
1
2007
172
0.060
Why?
Genomics
1
2008
266
0.060
Why?
Syndecan-1
2
2003
73
0.060
Why?
RNA, Messenger
2
2007
1134
0.060
Why?
Artificial Intelligence
1
2007
124
0.060
Why?
Adenomatous Polyposis Coli Protein
1
2005
3
0.060
Why?
Receptors, Atrial Natriuretic Factor
1
2005
8
0.060
Why?
Atrial Natriuretic Factor
1
2005
21
0.060
Why?
Ear, Inner
1
2005
20
0.060
Why?
Melanoma
1
2008
272
0.060
Why?
Guanine
1
2004
39
0.050
Why?
Cell Physiological Phenomena
1
2004
2
0.050
Why?
Cell Cycle Proteins
1
2005
168
0.050
Why?
Cytochromes c
1
2003
28
0.050
Why?
DNA Adducts
1
2004
79
0.050
Why?
Salivary Proteins and Peptides
1
2003
8
0.050
Why?
Statistics as Topic
1
2003
89
0.050
Why?
Isoenzymes
1
2003
171
0.050
Why?
Base Pair Mismatch
1
2003
21
0.050
Why?
Adenocarcinoma, Follicular
1
2003
3
0.050
Why?
Tunica Intima
1
2003
55
0.050
Why?
Adenocarcinoma, Papillary
1
2003
5
0.050
Why?
Adenoma, Oxyphilic
1
2003
11
0.050
Why?
Cell Count
1
2003
143
0.050
Why?
DNA-Binding Proteins
1
2005
423
0.050
Why?
Retrospective Studies
4
2007
6694
0.050
Why?
Keratoacanthoma
1
2002
7
0.050
Why?
Collagen
1
2003
215
0.050
Why?
Renal Dialysis
1
2003
189
0.050
Why?
Lung
1
2005
479
0.050
Why?
Combined Modality Therapy
4
2004
641
0.040
Why?
Alcohol Drinking
1
2003
235
0.040
Why?
Molecular Sequence Data
1
2003
778
0.040
Why?
Platelet Aggregation Inhibitors
1
2003
211
0.040
Why?
Blood Platelets
1
2003
239
0.040
Why?
Blotting, Western
2
2013
587
0.040
Why?
Adolescent
2
2012
6713
0.040
Why?
Cohort Studies
1
2005
1576
0.040
Why?
Tomography, X-Ray Computed
1
2006
1140
0.040
Why?
Prevalence
1
2004
1016
0.040
Why?
Smoking
1
2003
514
0.040
Why?
Random Allocation
2
2010
286
0.040
Why?
Quality of Life
1
2004
893
0.040
Why?
Electrophoresis, Agar Gel
2
2008
12
0.030
Why?
Sensitivity and Specificity
2
2010
871
0.030
Why?
Neck Dissection
2
2008
29
0.030
Why?
Hyperplasia
2
2008
96
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1365
0.030
Why?
Fluorouracil
2
2004
56
0.030
Why?
Photosensitivity Disorders
2
2003
10
0.030
Why?
Cross-Sectional Studies
2
2012
1677
0.030
Why?
Infant
2
2012
3709
0.020
Why?
Lymph Node Excision
2
2004
133
0.020
Why?
Head
1
2013
70
0.020
Why?
Actins
1
2013
112
0.020
Why?
Neck
1
2013
97
0.020
Why?
Treatment Outcome
3
2011
5508
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Antigens, Nuclear
1
2011
24
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
46
0.020
Why?
Tissue Culture Techniques
1
2011
42
0.020
Why?
Administration, Topical
1
2011
62
0.020
Why?
Transplantation, Heterologous
1
2011
78
0.020
Why?
Time Factors
2
2010
2987
0.020
Why?
Mice, Nude
1
2011
230
0.020
Why?
Neoplasms, Squamous Cell
1
2010
7
0.020
Why?
Rats
2
2009
3228
0.020
Why?
Pharmacogenetics
1
2010
51
0.020
Why?
Granulation Tissue
1
2010
10
0.020
Why?
Tissue and Organ Harvesting
1
2010
25
0.020
Why?
Myeloid Cells
1
2010
42
0.020
Why?
Probability
1
2010
171
0.020
Why?
Endothelial Cells
1
2011
283
0.020
Why?
Carcinoma
1
2010
135
0.020
Why?
Graft Rejection
1
2010
166
0.020
Why?
Pilot Projects
1
2011
725
0.020
Why?
Thymine
1
2008
10
0.020
Why?
Neovascularization, Physiologic
1
2009
86
0.020
Why?
Chi-Square Distribution
1
2009
292
0.020
Why?
Centromere
1
2008
12
0.020
Why?
Microdissection
1
2008
19
0.020
Why?
Cell Line, Transformed
1
2008
74
0.020
Why?
Telomere
1
2008
39
0.020
Why?
Gene Dosage
1
2008
73
0.020
Why?
Fluorescent Dyes
1
2008
91
0.020
Why?
Melanocytes
1
2008
38
0.020
Why?
Genetic Markers
1
2008
108
0.020
Why?
Iodine
1
2007
12
0.020
Why?
Predictive Value of Tests
1
2010
938
0.020
Why?
Mice, Knockout
1
2010
903
0.020
Why?
Fatal Outcome
1
2008
193
0.020
Why?
Cluster Analysis
1
2007
236
0.020
Why?
Epithelial Cells
1
2008
217
0.020
Why?
Prospective Studies
1
2011
2433
0.010
Why?
Buffers
1
2005
9
0.010
Why?
Round Window, Ear
1
2005
7
0.010
Why?
Rats, Inbred Lew
1
2005
49
0.010
Why?
Injections
1
2005
60
0.010
Why?
Rats, Sprague-Dawley
1
2009
1558
0.010
Why?
Phosphates
1
2005
51
0.010
Why?
Sodium Chloride
1
2005
55
0.010
Why?
Protein Isoforms
1
2005
127
0.010
Why?
Mice, Inbred C57BL
1
2010
1888
0.010
Why?
Drug Combinations
1
2005
136
0.010
Why?
Antibodies
1
2005
144
0.010
Why?
Reproducibility of Results
1
2007
1223
0.010
Why?
Statistics, Nonparametric
1
2004
199
0.010
Why?
Disease-Free Survival
1
2005
461
0.010
Why?
Platelet Adhesiveness
1
2003
14
0.010
Why?
Elastin
1
2003
23
0.010
Why?
Polytetrafluoroethylene
1
2003
33
0.010
Why?
Up-Regulation
1
2005
462
0.010
Why?
DNA Primers
1
2003
204
0.010
Why?
Radiotherapy
1
2004
128
0.010
Why?
Anastomosis, Surgical
1
2003
69
0.010
Why?
Vascular Patency
1
2003
82
0.010
Why?
Dogs
1
2003
183
0.010
Why?
Radiotherapy, Adjuvant
1
2003
65
0.010
Why?
Myocytes, Smooth Muscle
1
2003
95
0.010
Why?
Chemotherapy, Adjuvant
1
2003
122
0.010
Why?
Graft Occlusion, Vascular
1
2003
78
0.010
Why?
Extracellular Matrix
1
2003
116
0.010
Why?
Thyroidectomy
1
2003
61
0.010
Why?
Biopsy, Needle
1
2003
181
0.010
Why?
Lymphatic Metastasis
1
2003
210
0.010
Why?
Young Adult
1
2012
4346
0.010
Why?
Stromal Cells
1
2002
76
0.010
Why?
Models, Biological
1
2003
735
0.010
Why?
Diagnosis, Differential
1
2002
1028
0.010
Why?
Arkansas
1
2004
2013
0.010
Why?
Risk Assessment
1
2003
1349
0.010
Why?
Pregnancy
1
2003
2642
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description